Combining existing reports with the analysis presented in this study, it can be inferred that RORC, AR, LIN28B, IRF9, and IRF3 promoted prostate cancer lineage plasticity through the RTK/RAS pathway. This evidence concerns the gene IRF9 and prostate carcinoma.